Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Traci Lyons

Concepts (224)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Semaphorins
9
2025
37
5.530
Why?
Breast Neoplasms
26
2025
2382
4.660
Why?
Antigens, CD
10
2025
558
4.660
Why?
Mammary Glands, Animal
9
2025
128
2.540
Why?
Lymphatic Vessels
6
2024
63
2.530
Why?
Mammary Glands, Human
6
2024
68
2.450
Why?
Postpartum Period
11
2022
373
2.110
Why?
Cyclooxygenase 2
6
2020
166
1.940
Why?
Carcinoma, Intraductal, Noninfiltrating
2
2025
61
1.360
Why?
Breast
6
2024
156
1.320
Why?
Macrophages
5
2025
1507
1.270
Why?
GPI-Linked Proteins
8
2025
81
1.220
Why?
Carcinoma, Ductal, Breast
2
2025
89
0.970
Why?
Gene Expression Regulation, Neoplastic
6
2022
1443
0.940
Why?
Epithelial Cells
4
2024
1131
0.930
Why?
Cell Line, Tumor
14
2025
3542
0.910
Why?
Lymphangiogenesis
4
2024
27
0.890
Why?
B7-H1 Antigen
2
2025
244
0.870
Why?
Cell Plasticity
1
2025
37
0.870
Why?
Tumor Microenvironment
9
2025
734
0.830
Why?
Transforming Growth Factor beta1
1
2025
177
0.830
Why?
Immune Tolerance
1
2025
385
0.740
Why?
Puerperal Disorders
2
2014
36
0.700
Why?
Receptors, Estrogen
3
2021
401
0.700
Why?
Anoikis
1
2021
31
0.690
Why?
Mammary Neoplasms, Animal
3
2016
35
0.670
Why?
Mice
21
2025
18329
0.650
Why?
Antineoplastic Agents, Hormonal
2
2020
193
0.650
Why?
Neoplasm Metastasis
6
2025
688
0.640
Why?
Pregnancy Complications, Neoplastic
4
2026
63
0.640
Why?
Extracellular Matrix
5
2021
562
0.630
Why?
Animals
26
2025
38030
0.560
Why?
Drug Resistance, Neoplasm
2
2021
881
0.550
Why?
Lactation
4
2022
193
0.520
Why?
Programmed Cell Death 1 Receptor
1
2019
265
0.500
Why?
Neoplasm Invasiveness
6
2025
506
0.500
Why?
NF-kappa B
1
2019
666
0.470
Why?
Female
31
2026
78844
0.450
Why?
Proto-Oncogene Proteins c-akt
3
2021
440
0.430
Why?
Disease Models, Animal
6
2025
4560
0.420
Why?
Aging
1
2025
1969
0.420
Why?
Biomarkers, Tumor
2
2020
1321
0.410
Why?
Neoplasm Recurrence, Local
1
2020
1149
0.400
Why?
Pregnancy
11
2026
7202
0.390
Why?
Cell Movement
6
2022
959
0.380
Why?
Xenograft Model Antitumor Assays
4
2020
934
0.370
Why?
Carcinoma, Ductal
1
2011
10
0.350
Why?
Fibrillar Collagens
1
2011
14
0.350
Why?
Collagen
3
2025
457
0.340
Why?
Mice, Knockout
4
2025
3124
0.340
Why?
Humans
34
2026
145474
0.330
Why?
Mice, Inbred BALB C
3
2019
1261
0.320
Why?
Disease Progression
4
2025
2864
0.300
Why?
Antigens, Differentiation, Myelomonocytic
2
2019
66
0.280
Why?
Cell Survival
2
2021
1100
0.260
Why?
Membrane Glycoproteins
2
2019
499
0.240
Why?
Signal Transduction
6
2025
5216
0.230
Why?
Mice, SCID
2
2020
369
0.230
Why?
Cell Transformation, Neoplastic
2
2021
337
0.230
Why?
Ubiquitin-Protein Ligases
1
2007
192
0.230
Why?
Apoptosis
2
2020
2440
0.230
Why?
Prognosis
4
2020
4316
0.220
Why?
Mice, Inbred C57BL
4
2021
5983
0.220
Why?
Mice, Inbred NOD
3
2021
613
0.210
Why?
Chitin
1
2024
9
0.210
Why?
Chitinases
1
2024
9
0.210
Why?
Lymphatic System
1
2024
15
0.210
Why?
Lymphatic Metastasis
4
2024
331
0.200
Why?
Epithelial-Mesenchymal Transition
1
2025
219
0.200
Why?
Celecoxib
2
2014
42
0.190
Why?
Biology
1
2024
88
0.190
Why?
Head and Neck Neoplasms
2
2020
561
0.190
Why?
Disease-Free Survival
2
2021
767
0.180
Why?
Immune Evasion
1
2022
61
0.180
Why?
Receptors, CXCR3
1
2022
17
0.180
Why?
Immunohistochemistry
2
2019
1716
0.180
Why?
Chemokine CXCL9
1
2022
38
0.180
Why?
Integrin alpha6
1
2021
9
0.180
Why?
Chemokine CXCL10
1
2022
39
0.180
Why?
Caspase 7
1
2021
22
0.180
Why?
Integrin beta1
1
2021
33
0.170
Why?
Gene Knockdown Techniques
2
2020
333
0.170
Why?
Melanoma, Experimental
1
2022
109
0.170
Why?
Triple Negative Breast Neoplasms
1
2024
218
0.170
Why?
Mammals
1
2022
286
0.160
Why?
Fibronectins
2
2020
136
0.160
Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2020
35
0.160
Why?
Caspase 3
1
2021
242
0.160
Why?
Cytoskeletal Proteins
1
2021
156
0.160
Why?
Actin Cytoskeleton
1
2021
103
0.160
Why?
Hyaluronan Receptors
1
2020
104
0.160
Why?
Enzyme Activation
1
2021
762
0.150
Why?
Adipocytes
1
2021
223
0.150
Why?
Models, Biological
3
2019
1764
0.150
Why?
Maternal Age
1
2020
128
0.150
Why?
Receptors, G-Protein-Coupled
1
2022
231
0.150
Why?
Kaplan-Meier Estimate
2
2020
969
0.150
Why?
Estrogens
2
2020
367
0.150
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
977
0.140
Why?
Mammary Neoplasms, Experimental
1
2019
62
0.140
Why?
Genes, Reporter
1
2019
277
0.140
Why?
Tumor Cells, Cultured
1
2020
886
0.140
Why?
Pyrazoles
2
2014
517
0.140
Why?
Sulfonamides
2
2014
583
0.140
Why?
Actins
1
2021
425
0.140
Why?
Phosphorylation
2
2021
1707
0.140
Why?
Crosses, Genetic
1
2018
123
0.140
Why?
Integrins
1
2018
90
0.130
Why?
Extracellular Vesicles
1
2020
171
0.130
Why?
Cell Proliferation
3
2020
2507
0.130
Why?
Antibodies, Monoclonal
1
2025
1505
0.130
Why?
RNA, Small Interfering
1
2020
637
0.130
Why?
Protein Binding
2
2022
2238
0.130
Why?
Podosomes
1
2016
4
0.120
Why?
Adaptor Proteins, Vesicular Transport
1
2016
45
0.120
Why?
Neoplasms
2
2026
2906
0.120
Why?
Neoplastic Stem Cells
1
2020
409
0.120
Why?
Genetic Pleiotropy
1
2016
30
0.120
Why?
rab GTP-Binding Proteins
1
2016
76
0.120
Why?
Survival Rate
1
2020
2090
0.110
Why?
Protein Kinase Inhibitors
1
2021
981
0.110
Why?
Melanoma
1
2022
759
0.110
Why?
Phenotype
2
2021
3155
0.110
Why?
Skin Neoplasms
1
2022
849
0.100
Why?
Blotting, Western
3
2011
1179
0.100
Why?
Dinoprostone
1
2014
180
0.100
Why?
CD8-Positive T-Lymphocytes
1
2019
919
0.090
Why?
CD4-Positive T-Lymphocytes
1
2019
1140
0.090
Why?
Endothelial Cells
1
2018
874
0.090
Why?
Drug Design
1
2013
175
0.090
Why?
Adult
7
2025
40777
0.090
Why?
Hematopoietic Stem Cells
1
2015
435
0.090
Why?
Ibuprofen
1
2011
87
0.080
Why?
Risk
2
2013
919
0.080
Why?
In Situ Hybridization, Fluorescence
1
2011
325
0.080
Why?
Time Factors
4
2020
7123
0.080
Why?
BRCA1 Protein
1
2010
82
0.070
Why?
Cohort Studies
1
2020
6013
0.070
Why?
Macrophage Activation
1
2010
181
0.070
Why?
Analysis of Variance
1
2011
1300
0.070
Why?
Mutation
1
2019
4075
0.070
Why?
Stromal Cells
1
2009
121
0.070
Why?
Incidence
2
2020
2923
0.070
Why?
Tamoxifen
1
2009
191
0.070
Why?
Extracellular Matrix Proteins
1
2009
156
0.070
Why?
Gonadal Steroid Hormones
1
2009
143
0.070
Why?
Insulin-Like Growth Factor I
1
2010
317
0.060
Why?
Restriction Mapping
1
2007
81
0.060
Why?
Intercellular Signaling Peptides and Proteins
1
2009
376
0.060
Why?
Disease Susceptibility
1
2009
344
0.060
Why?
Cloning, Molecular
1
2007
538
0.060
Why?
Estradiol
1
2010
515
0.060
Why?
Cell Line
2
2010
2823
0.060
Why?
Recombinant Fusion Proteins
1
2007
666
0.050
Why?
Phosphatidylinositol 3-Kinases
2
2020
382
0.050
Why?
Base Sequence
1
2007
2170
0.050
Why?
Immunotherapy
2
2022
666
0.050
Why?
Molecular Sequence Data
1
2007
2883
0.050
Why?
Young Adult
3
2020
14218
0.050
Why?
Cell Cycle Proteins
2
2020
630
0.040
Why?
Antineoplastic Agents
1
2013
2214
0.040
Why?
Stress Fibers
1
2021
18
0.040
Why?
T-Lymphocytes, Cytotoxic
1
2022
177
0.040
Why?
Focal Adhesions
1
2021
47
0.040
Why?
Zinc Finger E-box-Binding Homeobox 1
1
2020
21
0.040
Why?
Lymphocytes, Tumor-Infiltrating
1
2022
153
0.040
Why?
Tumor Burden
1
2022
325
0.040
Why?
Feedback, Physiological
1
2020
80
0.040
Why?
Pregnancy-Associated Plasma Protein-A
1
2020
14
0.040
Why?
SOXB1 Transcription Factors
1
2020
67
0.040
Why?
Kidney
1
2007
1497
0.040
Why?
Cell Adhesion
1
2020
451
0.040
Why?
Proteomics
2
2020
1188
0.040
Why?
Cell Communication
1
2020
328
0.040
Why?
Ki-67 Antigen
1
2019
117
0.030
Why?
Parity
1
2019
111
0.030
Why?
Survival Analysis
1
2022
1374
0.030
Why?
Hyaluronic Acid
1
2020
226
0.030
Why?
Rats
3
2013
5584
0.030
Why?
Proteins
1
2024
1023
0.030
Why?
Monocytes
1
2020
539
0.030
Why?
Adaptor Proteins, Signal Transducing
1
2020
425
0.030
Why?
Neoplasm Proteins
1
2020
441
0.030
Why?
Matrix Metalloproteinase 2
1
2016
56
0.030
Why?
Global Health
1
2020
403
0.030
Why?
Matrix Metalloproteinase 9
1
2016
131
0.030
Why?
Breast Feeding
1
2020
446
0.030
Why?
Lymph Nodes
1
2019
503
0.030
Why?
Protein Domains
1
2016
311
0.030
Why?
Neoplasm Staging
1
2019
1471
0.030
Why?
Rats, Sprague-Dawley
2
2010
2524
0.020
Why?
Gene Expression Profiling
1
2020
1767
0.020
Why?
Bone Marrow
1
2015
306
0.020
Why?
Case-Control Studies
1
2020
3623
0.020
Why?
Cadherins
1
2013
200
0.020
Why?
Risk Factors
2
2019
10885
0.020
Why?
Liver
1
2020
1896
0.020
Why?
Middle Aged
3
2020
36215
0.020
Why?
MicroRNAs
1
2016
686
0.020
Why?
Weaning
1
2010
51
0.020
Why?
Receptor, IGF Type 1
1
2010
64
0.020
Why?
Immunoprecipitation
1
2010
148
0.020
Why?
Proportional Hazards Models
1
2013
1327
0.020
Why?
Matrix Metalloproteinases
1
2010
95
0.020
Why?
Multivariate Analysis
1
2013
1547
0.020
Why?
Mitogen-Activated Protein Kinase 1
1
2010
171
0.020
Why?
Fluorescent Antibody Technique
1
2010
365
0.020
Why?
Proteasome Endopeptidase Complex
1
2010
155
0.020
Why?
Species Specificity
1
2010
546
0.020
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2009
143
0.020
Why?
Protein Transport
1
2010
442
0.020
Why?
Biomarkers
2
2010
4295
0.020
Why?
Cytokines
1
2015
2067
0.020
Why?
Mice, Nude
1
2009
679
0.020
Why?
Cell Cycle
1
2010
598
0.020
Why?
Mass Spectrometry
1
2010
730
0.020
Why?
Recombinant Proteins
1
2010
1368
0.020
Why?
Cell Culture Techniques
1
2009
372
0.010
Why?
Fibroblasts
1
2009
1025
0.010
Why?
Cells, Cultured
1
2010
4148
0.010
Why?
Adolescent
1
2020
22529
0.010
Why?
Retrospective Studies
1
2013
17291
0.010
Why?
Male
1
2020
72842
0.010
Why?
Aged
1
2010
26153
0.000
Why?
Lyons's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)